About this episode

This episode discusses how pharmaceutical companies can improve their launch processes by adopting flexible frameworks and strong governance.

Most pharma launch frameworks don’t fail because they lack structure; they fail because they become rigid checklists that kill strategic thinking. In this episode, Lumanity’s Business Development Director, Jeff Hart, and Launch Excellence Principal, Kirsty Tait, talk about how pharmaceutical companies can scale launch excellence as pipelines grow and complexity increases. Kirsty and Jeff explain that rigid, one-size-fits-all frameworks lead to inefficiency, slow decisions, and misalignment across global and local teams. Instead, organizations need a standardized operating system with built-in flexibility to tailor strategy by asset and market. Ultimately, success depends not just on process, but on strong governance, a single source of truth, and a winning culture that drives execution. If your launch process feels slow, inconsistent, or overly complex, this conversation will help you rethink how to scale without losing speed or impact. Resources: Follow Lumanity on LinkedIn and explore their website! Connect with and follow Kirsty Tait on LinkedIn. Connect with and follow Jeff Hart on LinkedIn.Take a look at the Launch Excellence Health Check here! Learn more about this series…

People in this episode

Host: Saul Marquez

Guests: Jeff Hart, Kirsty Tait

Topics covered

• pharmaceutical launch
• strategic thinking
• launch excellence
• organizational efficiency
• governance
• market strategy

Keywords

• pharma launch
• strategic frameworks
• efficiency
• governance
• market complexity
• launch excellence
• organizational culture

Mentioned in this episode

Organizations: Lumanity

More episodes of Outcomes Rocket

• From One Event to a Global Platform: The Rise of MedTech World with Dr. Dylan Attard, CEO and Co-founder of MedTech World · June 4, 2026 · 9 min
• Reinventing Blood Testing for Better Patient Experience with Web Golinkin, President at Babson Diagnostics · May 28, 2026 · 22 min
• From Innovation to Adoption: What It Really Takes to Win in Medtech with Ken Nelson, Partner and Founder at Nelson Jennings Ventures · May 28, 2026 · 7 min
• Shifting from Denial Management to Denial Prevention with Jason Considine, President of Experian Health · May 27, 2026 · 22 min
• Building Trustworthy AI in Healthcare with Dr. Peter Bonis, Chief Medical Officer at Wolters Kluwer Health · May 26, 2026 · 17 min
• Designing for the End: Bridging Medtech Development and Manufacturing with Amanda Helgeson, Business Development Manager at Forj Medical · May 26, 2026 · 9 min

Explore listener stats, chart rankings, contacts and more on the Outcomes Rocket podcast page.